The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A retrospective study of a dexamethasone-sparing strategy of preventing acute and delayed emesis caused by CapeOx regimen with aprepitant for colorectal cancer.
 
Miho Nakatsuka
No Relationships to Disclose
 
Daisuke Sakai
Speakers' Bureau - Chugai Pharma
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo; Lilly Japan; Ono Pharmaceutical (Inst); Yakult Honsha (Inst)
 
Yasushi Murachi
No Relationships to Disclose
 
Naohiro Nishida
No Relationships to Disclose
 
Toshihiro Kudo
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Lilly; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Bayer Yakuhin
Research Funding - Bayer Yakuhin; Chugai Pharma; Lilly; Ono Pharmaceutical; Yakult Honsha
 
Akie Kimura
No Relationships to Disclose
 
Toru Otsuru
No Relationships to Disclose
 
Hidekazu Takahashi
No Relationships to Disclose
 
Norikatsu Miyoshi
No Relationships to Disclose
 
Naotsugu Haraguchi
No Relationships to Disclose
 
Chu Matsuda
No Relationships to Disclose
 
Hiroko Kadowaki
No Relationships to Disclose
 
Tomoya Yamamoto
No Relationships to Disclose
 
Yoshitaka Kuritani
No Relationships to Disclose
 
Tsunekazu Mizushima
No Relationships to Disclose
 
Yuichiro Doki
No Relationships to Disclose
 
Masaki Mori
No Relationships to Disclose
 
Yoshihior Miwa
No Relationships to Disclose
 
Taroh Satoh
Honoraria - Astellas Pharma; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Lilly; Merck; Merck Serono; Ono Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Bayer Yakuhin; Lilly; Merck Serono; Ono Pharmaceutical; Takara Bio
Research Funding - Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Gilead Sciences (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Yakult Honsha (Inst)